BCI
CDMO

Brinker Capital Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Brinker Capital Investments’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,263
Closed -$157K – 1407
2022
Q2 		$157K Buy
+10,263
New +$152K ﹤0.01% 1317
2022
Q1 		– Sell
-8,916
Closed -$260K – 1422
2021
Q4 		$260K Buy
+8,916
New +$255K ﹤0.01% 1298

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brinker Capital Investments's CDMO Position: Q3 2022 in Review

Brinker Capital Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 10,263 shares — an estimated $157K sold.

Brinker Capital Investments first reported a position in CDMO in Q4 2021 and held it in 2 quarters. The position peaked at $260K in Q4 2021. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

  • Brinker Capital Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 10,263 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $157K.
  • Brinker Capital Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Brinker Capital Investments's Avid Bioservices, Inc. Common Stock position peaked at $260K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on Brinker Capital Investments's 13F filing for Q3 2022, filed 1 Nov 2022.